Latanoprost Teva

Latanoprost, the active ingredient in Latanoprost Teva, is a prostaglandin analog presented as a eye drops for ocular use. It treats primary open-angle glaucoma and ocular hypertension by lowering intra‑ocular pressure.

GNH USA supplies Latanoprost Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanoprost is a prostaglandin analog used in glaucoma and ocular hypertension management.

Primary open-angle glaucoma: reduces intra‑ocular pressure to slow disease progression. Ocular hypertension: lowers intra‑ocular pressure to prevent conversion to glaucoma. Secondary open-angle glaucoma: helps control pressure in cases such as pseudoexfoliative glaucoma.

Latanoprost may cause ocular and systemic reactions.

Common Side Effects: - Eye redness or hyperemia. - Increased eyelash length and thickness. - Darkening of the iris color. - Eye irritation or foreign‑body sensation. - Blurred vision. - Mild eye discomfort.

Serious or Rare Side Effects: - Severe ocular inflammation (uveitis or iritis). - Allergic reactions such as swelling or rash. - Paradoxical rise in intra‑ocular pressure. - Corneal edema or clouding. - Vision loss. - Persistent eye pain.

Before initiating therapy, consider the following precautions.

Monitor IOP: regular intra‑ocular pressure measurements are required. Assess for infection: avoid use if active ocular infection is present. Avoid contact lenses: discontinue lens wear during treatment. Pregnancy and lactation: use only if potential benefit justifies potential risk. Drug interactions: be cautious when using other prostaglandin analog eye drops. Store at room temperature: keep in the original container, protect from light and moisture.

Latanoprost may interact with other ocular or systemic agents.

Major Interactions (Avoid): - Concomitant use with other prostaglandin analog eye drops: increased risk of adverse ocular effects. - Use with systemic carbonic anhydrase inhibitors: additive IOP‑lowering may cause hypotony. - Use around ocular surgery: may interfere with wound healing.

Moderate Interactions (Monitor Closely): - Nonsteroidal anti‑inflammatory eye drops: may reduce Latanoprost efficacy. - Beta‑blocker eye drops: additive IOP‑lowering effect requires monitoring. - Anticholinergic eye drops: possible reduction in therapeutic response.